181 related articles for article (PubMed ID: 21527533)
1. The cytochrome P450 4A/F-20-hydroxyeicosatetraenoic acid system: a regulator of endothelial precursor cells derived from human umbilical cord blood.
Guo AM; Janic B; Sheng J; Falck JR; Roman RJ; Edwards PA; Arbab AS; Scicli AG
J Pharmacol Exp Ther; 2011 Aug; 338(2):421-9. PubMed ID: 21527533
[TBL] [Abstract][Full Text] [Related]
2. CYP4A/20-HETE regulates ischemia-induced neovascularization via its actions on endothelial progenitor and preexisting endothelial cells.
Chen L; Tang S; Zhang FF; Garcia V; Falck JR; Schwartzman ML; Arbab AS; Guo AM
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1468-H1479. PubMed ID: 30951365
[TBL] [Abstract][Full Text] [Related]
3. 20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo.
Chen L; Ackerman R; Saleh M; Gotlinger KH; Kessler M; Mendelowitz LG; Falck JR; Arbab AS; Scicli AG; Schwartzman ML; Yang J; Guo AM
J Pharmacol Exp Ther; 2014 Mar; 348(3):442-51. PubMed ID: 24403517
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of cytochrome P450 4A suppress angiogenic responses.
Chen P; Guo M; Wygle D; Edwards PA; Falck JR; Roman RJ; Scicli AG
Am J Pathol; 2005 Feb; 166(2):615-24. PubMed ID: 15681843
[TBL] [Abstract][Full Text] [Related]
5. Human U251 glioma cell proliferation is suppressed by HET0016 [N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine], a selective inhibitor of CYP4A.
Guo M; Roman RJ; Falck JR; Edwards PA; Scicli AG
J Pharmacol Exp Ther; 2005 Nov; 315(2):526-33. PubMed ID: 16081682
[TBL] [Abstract][Full Text] [Related]
6. Astrocytic cytochrome P450 4A/20-hydroxyeicosatetraenoic acid contributes to angiogenesis in the experimental ischemic stroke.
Liu Y; Li Y; Zhan M; Liu Y; Li Z; Li J; Cheng G; Teng G; Lu L
Brain Res; 2019 Apr; 1708():160-170. PubMed ID: 30571981
[TBL] [Abstract][Full Text] [Related]
7. Expression of CYP4A1 in U251 human glioma cell induces hyperproliferative phenotype in vitro and rapidly growing tumors in vivo.
Guo AM; Sheng J; Scicli GM; Arbab AS; Lehman NL; Edwards PA; Falck JR; Roman RJ; Scicli AG
J Pharmacol Exp Ther; 2008 Oct; 327(1):10-9. PubMed ID: 18591218
[TBL] [Abstract][Full Text] [Related]
8. 20-HETE in neovascularization.
Chen L; Ackerman R; Guo AM
Prostaglandins Other Lipid Mediat; 2012 Aug; 98(3-4):63-8. PubMed ID: 22227460
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 4A isoform inhibitory profile of N-hydroxy-N'-(4-butyl-2-methylphenyl)-formamidine (HET0016), a selective inhibitor of 20-HETE synthesis.
Seki T; Wang MH; Miyata N; Laniado-Schwartzman M
Biol Pharm Bull; 2005 Sep; 28(9):1651-4. PubMed ID: 16141533
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma.
Wang C; Li Y; Chen H; Zhang J; Zhang J; Qin T; Duan C; Chen X; Liu Y; Zhou X; Yang J
Cancer Lett; 2017 Aug; 402():131-141. PubMed ID: 28602979
[TBL] [Abstract][Full Text] [Related]
11. Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes.
Yousif MH; Benter IF; Dunn KM; Dahly-Vernon AJ; Akhtar S; Roman RJ
Auton Autacoid Pharmacol; 2009 Jan; 29(1-2):1-12. PubMed ID: 19302551
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of 20-hydroxyeicosatetraenoic acid (20-HETE) formation attenuate the natriuretic effect of dopamine.
Fernandez MM; Gonzalez D; Williams JM; Roman RJ; Nowicki S
Eur J Pharmacol; 2012 Jul; 686(1-3):97-103. PubMed ID: 22575524
[TBL] [Abstract][Full Text] [Related]
13. 9L gliosarcoma cell proliferation and tumor growth in rats are suppressed by N-hydroxy-N'-(4-butyl-2-methylphenol) formamidine (HET0016), a selective inhibitor of CYP4A.
Guo M; Roman RJ; Fenstermacher JD; Brown SL; Falck JR; Arbab AS; Edwards PA; Scicli AG
J Pharmacol Exp Ther; 2006 Apr; 317(1):97-108. PubMed ID: 16352703
[TBL] [Abstract][Full Text] [Related]
14. Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation.
Guo AM; Arbab AS; Falck JR; Chen P; Edwards PA; Roman RJ; Scicli AG
J Pharmacol Exp Ther; 2007 Apr; 321(1):18-27. PubMed ID: 17210799
[TBL] [Abstract][Full Text] [Related]
15. Human umbilical cord blood-derived CD34-positive endothelial progenitor cells stimulate osteoblastic differentiation of cultured human periosteal-derived osteoblasts.
Lee JH; Hah YS; Cho HY; Kim JH; Oh SH; Park BW; Kang YH; Choi MJ; Shin JK; Rho GJ; Jeon RH; Lee HC; Kim GC; Kim UK; Kim JR; Lee CI; Byun JH
Tissue Eng Part A; 2014 Mar; 20(5-6):940-53. PubMed ID: 24168264
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin-mediated cytotoxicity through inducing CYP4A 11 expression in human renal tubular epithelial cells.
Li J; Li D; Tie C; Wu J; Wu Q; Li Q
J Toxicol Sci; 2015 Dec; 40(6):895-900. PubMed ID: 26558470
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the Role of Fatty Acid-Metabolizing CYP4F11 in Lung Cancer and Its Potential As a Drug Target.
Jia H; Brixius B; Bocianoski C; Ray S; Koes DR; Brixius-Anderko S
Drug Metab Dispos; 2024 Jan; 52(2):69-79. PubMed ID: 37973374
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of endothelial cells from human umbilical cord blood AC133-CD14+ cells.
Kim SY; Park SY; Kim JM; Kim JW; Kim MY; Yang JH; Kim JO; Choi KH; Kim SB; Ryu HM
Ann Hematol; 2005 Jul; 84(7):417-22. PubMed ID: 15711948
[TBL] [Abstract][Full Text] [Related]
19. Vascular characterization of mice with endothelial expression of cytochrome P450 4F2.
Cheng J; Edin ML; Hoopes SL; Li H; Bradbury JA; Graves JP; DeGraff LM; Lih FB; Garcia V; Shaik JS; Tomer KB; Flake GP; Falck JR; Lee CR; Poloyac SM; Schwartzman ML; Zeldin DC
FASEB J; 2014 Jul; 28(7):2915-31. PubMed ID: 24668751
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cytochrome P450 4 family as mediator of phospholipase D activation in aortic vascular smooth muscle cells.
Parmentier JH; Lavrentyev EN; Falck JR; Capdevila JH; Malik KU
Life Sci; 2005 Jul; 77(9):1015-29. PubMed ID: 15964316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
